Professor Lars Lund

Professor Lars Lund

Karolinska University Hospital, Stockholm (Sweden)

Member of:

Lars Lund is Professor of Cardiology at Karolinska Institutet and Karolinska University Hospital in Stockholm. His research focuses on heart failure: implementation of existing therapy in HFrEF and development of novel therapy in HFpEF.

Sessions Presentations Events Articles

Remote care in heart failure - challenges and solutions

Event: Heart Failure 2025

Topic: Multidisciplinary Interventions

Session type: Moderated ePosters

Access

Does aldosterone synthase inhibition hold a key to transforming cardiorenal care?

Event: Heart Failure 2025

Topic: Aldosterone Antagonists

Session type: Satellite Symposium

Access

Indications for implantable cardioverter-defibrillator implantation: time to go beyond left ventricular ejection fraction (LVEF)?

Event: Heart Failure 2025

Topic: Ventricular Assist Devices

Session type: Debate Session

Access

Research methodology

Event: Heart Failure 2024

Topic: Research Methodology

Session type: Moderated ePosters

Access

Late breaking science: registries

Event: Heart Failure 2024

Topic: Heart Failure Association (HFA)

Session type: Late-Breaking Science

Access

New tools to detect and treat acute heart failure

Event: Heart Failure 2024

Topic: Acute Heart Failure

Session type: Rapid Fire Abstracts

Access

Registry-based research in heart failure: when is it useful?

Event: Heart Failure 2023

Topic: Big Data Analysis

Session type: Symposium

Access

HF clinical trials of 2022

Event: Heart Failure 2023

Topic: Heart Failure Association (HFA)

Session type: Case-Based Session

Access

Chronic heart failure - HFpEF - HFrEF - HFmREF

Event: ESC Congress 2022

Topic: Pathophysiology and Mechanisms

Session type: Moderated ePosters

Access

HFpEF and HFmrEF: what’s new in treatment?

Event: ESC Congress 2022

Topic: Pathophysiology and Mechanisms

Session type: Abstract Sessions

Access

ESC 365 is supported by

Explore sponsored resources

Professor Lars Lund

Biography

Contributor content

Remote care in heart failure - challenges and solutions

Does aldosterone synthase inhibition hold a key to transforming cardiorenal care?

Indications for implantable cardioverter-defibrillator implantation: time to go beyond left ventricular ejection fraction (LVEF)?

Research methodology

Late breaking science: registries

New tools to detect and treat acute heart failure

Registry-based research in heart failure: when is it useful?

HF clinical trials of 2022

Chronic heart failure - HFpEF - HFrEF - HFmREF

HFpEF and HFmrEF: what’s new in treatment?

ESC 365 is supported by

Professor Lars Lund Follow

Biography

Contributor content

Remote care in heart failure - challenges and solutions

Does aldosterone synthase inhibition hold a key to transforming cardiorenal care?

Indications for implantable cardioverter-defibrillator implantation: time to go beyond left ventricular ejection fraction (LVEF)?

Research methodology

Late breaking science: registries

New tools to detect and treat acute heart failure

Registry-based research in heart failure: when is it useful?

HF clinical trials of 2022

Chronic heart failure - HFpEF - HFrEF - HFmREF

HFpEF and HFmrEF: what’s new in treatment?

ESC 365 is supported by

Professor Lars Lund